OLMA
Olema Pharmaceuticals, Inc.After hours7.02−0.34 −4.62%USD
NasdaqGS · as of Oct 13, 16:00 ET · 15m delayAfter hours 7.02 0.00%
Open
7.30
Prev close
7.36
Day range
7.007.36
52-week range
6.6536.26
Volume
1.42M1.35×
Mkt cap
614.23M
P/E ttm
—
Fwd P/E
-2.66
EPS ttm
-2.12
Div yield
0.00%
Earnings
—
From 52w high
−80.64%
OLMA earnings and estimates
OLMA Next Report
Yahoo Finance · Nasdaq
Report date
Mon, Nov 9
After the close · estimated
EPS consensus
$−0.63
range −0.73 – −0.50
EPS growth vs year ago
−29.4%
year ago −0.49
Revenue consensus
$0
0.0% vs year ago
Options-implied move
±54.8%
by Nov 20 · ATM straddle
Past 4 reactions
±8.9%
average move · beat 2 of 4
EPS: Actual vs Estimate
Price Reaction
close before → close after the report
Recent Reports
| Quarter ending | Reported | EPS | Estimate | Surprise | Revenue | Next session | Five sessions |
|---|---|---|---|---|---|---|---|
| Jun '26 | Aug 10, 2026 AMC | −0.61 | −0.56 | −8.19% | $0 | −12.6% | −9.8% |
| Mar '26 | May 12, 2026 BMO | −0.52 | −0.54 | +3.51% | $0 | −6.0% | −13.2% |
| Dec '25 | Mar 16, 2026 BMO | −0.50 | −0.53 | +5.10% | $0 | +12.8% | −4.3% |
| Sep '25 | Nov 10, 2025 BMO | −0.49 | −0.45 | −8.49% | $0 | +4.2% | +0.6% |
Consensus Estimates and Revisions
| Period | EPS | Low · range · high | Growth | Revenue | Growth | 30d ago | 90d ago | Up / down (30d) |
|---|---|---|---|---|---|---|---|---|
| Current quarter Sep 2026 | −0.63 | −0.73−0.50 | −29.4% | $0 | 0.0% | −0.65 +1.7% | −0.58 −9.5% | 1 / 7 |
| Next quarter Dec 2026 | −0.66 | −0.73−0.52 | −31.2% | $0 | 0.0% | −0.67 +2.0% | −0.61 −6.7% | 1 / 7 |
| Current year Dec 2026 | −2.38 | −2.69−1.92 | −27.2% | $0 | 0.0% | −2.42 +1.8% | −2.27 −4.6% | 1 / 7 |
| Next year Dec 2027 | −2.64 | −3.09−2.04 | −10.9% | $6.34M | 0.0% | −2.69 +1.9% | −2.48 −6.3% | 1 / 7 |
The change columns show how the consensus has moved since then; steady upward revisions often precede beats. Ranges place the consensus between the lowest and highest analyst estimate.
Forward EPS Forecasts
Nasdaq · Zacks consensus
Quarterly
| Fiscal period | Consensus | Low · range · high | Analysts | Up / down (4w) |
|---|---|---|---|---|
| Sep 2026 | −0.60 | −0.65−0.50 | 5 | 0 / 0 |
| Dec 2026 | −0.64 | −0.70−0.52 | 5 | 0 / 0 |
| Mar 2027 | −0.62 | −0.72−0.55 | 3 | 0 / 0 |
| Jun 2027 | −0.66 | −0.75−0.61 | 3 | 0 / 0 |
| Sep 2027 | −0.71 | −0.79−0.65 | 3 | 0 / 0 |
Fiscal years
| Fiscal period | Consensus | Low · range · high | Analysts | Up / down (4w) |
|---|---|---|---|---|
| Dec 2026 | −2.43 | −2.45−2.36 | 4 | 0 / 0 |
| Dec 2027 | −2.72 | −3.09−2.49 | 5 | 0 / 0 |
| Dec 2028 | −2.16 | −2.36−1.93 | 3 | 1 / 0 |
| Dec 2029 | −1.54 | −1.69−1.39 | 2 | 0 / 0 |
Reactions run from the last close before a report to the first close after it (an after-the-close report is measured to the next day's close). The implied move is the at-the-money straddle for the first expiry after the report, the same rule as the bot's lgf emove.